Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer

NCT04829890 · clinicaltrials.gov ↗

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Adenocarcinoma of Breast

Sponsor

Hellenic Cooperative Oncology Group